Answers are grounded in this paper and cite their sources.
Microbial β-galactosidase plays a central role in dairy processing because of its applications in lactose hydrolysis and galactooligosaccharide (GOS) synthesis. However, despite decades of research and technological development, it remains unclear how scientific advances have translated into industrial innovation and which microbial platforms are shaping the future of dairy biotechnology. This study integrates scientific literature ranked using the Methodi Ordinatio methodology with patent analysis to provide a comprehensive overview of microbial β-galactosidase production. A total of 100 scientific articles and 49 granted patents were analyzed. Lactic acid bacteria predominated in scientific literature (45%), whereas patents placed greater emphasis on industrially established microorganisms, particularly Bacillus spp., together with recombinant production strategies. Although lactose hydrolysis and GOS production remained the predominant applications, emerging trends point toward probiotic microorganisms capable of producing β-galactosidase while supporting the development of functional dairy products, psychrotrophic species for refrigerated dairy processing, microalgae as alternative microbial platforms, and the use of agro-industrial residues to promote more sustainable bioprocesses within a circular bioeconomy. By integrating scientific and technological evidence, this review identifies the microbial platforms and production strategies that are shaping the next generation of dairy innovation.
No takes yet. Share an insight, caveat, or question.
Moura et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: